Chapter III: Supervisory Board, Executive Board and Management Board

Articles in this section · 19

Article L6143-4

French Public Health CodeIn force

Updated 6 Nov 2023

The decisions of the Supervisory Board referred to in Article L. 6143-1 and the acts of the Director referred to in Article L. 6143-7 are enforceable subject to the following conditions:

1° The decisions of the Supervisory Board referred to in 2°, 5°, 7° and 8° of article L. 6143-1 are enforceable if the Director General of the Regional Health Agency does not object within two months of either the meeting of the Supervisory Board if he attended it, or receipt of the decision in other cases. The decisions referred to in 3° of the same article are automatically enforceable upon receipt by the Director General of the Regional Health Agency;

2° The decisions of the Director referred to in 1° to 10° and 12° to 16° of Article L. 6143-7 are automatically enforceable upon receipt by the Director General of the Regional Health Agency, with the exception of the decisions referred to in 1° and 5° of the same Article;

2° bis The statement of projected income and expenditure, excluding annexes, and the multi-year global financing plan, mentioned in 5° of Article L. 6143-7, are deemed to be approved if the Director General of the Regional Health Agency has not made his opposition known within a period and on grounds determined by decree.

For health care institutions subject to a recovery plan in application of article L. 6143-3, the statement of projected revenue and expenditure and its appendices, as well as the multi-year global financing plan, mentioned in 5° of article L. 6143-7, are subject to the express approval of the Director General of the Regional Health Agency.

In the case provided for in the second paragraph of this 2° bis, the statement of projected income and expenditure may not be approved by the Director General of the Regional Health Agency if the increase in staff numbers is manifestly incompatible with the increase in the activity of the health care organisation.

The terms and conditions for the application of the second and third paragraphs of this 2° bis are set by decree;

For each of the health care institutions that are part of a regional hospital grouping, the Director General of the Regional Health Agency takes into account all the budgets of the institutions in the regional hospital grouping when assessing the statement of projected income and expenditure and the multi-annual global funding plan referred to in 5° of Article L. 6143-7 ;

3° The decisions of the Director of Assistance publique-hôpitaux de Paris relating to the investment programme and the multiannual global financing plan mentioned in 4° and 5° of Article L. 6143-7 are deemed to have been approved if the Director General of the Regional Health Agency and the Ministers responsible for Health, Social Security and the Budget have not made their opposition known within the time limits laid down by regulation, on the grounds that they do not comply with the laws and regulations in force or are incompatible with maintaining the balance or the recovery of the institution.

When Assistance publique-hôpitaux de Paris' revenue and expenditure forecasts are presented as unbalanced, the Director General of the Regional Health Agency may approve them under the conditions laid down in 2°a of this article, after receiving the assent of the Ministers for Health, Social Security and the Budget.

The contract referred to in 1° of article L. 6143-7 is enforceable as soon as it has been signed by all the parties.

The Inter-regional Health and Social Pricing Tribunal, referred to in article L. 351-1 of the Code de l'action sociale et des familles, has jurisdiction at first instance to rule on appeals lodged against the opposition of the Director General of the Regional Health Agency to the approval of the statement of projected income and expenditure or its amendments in application of 2° bis of this article. It also has jurisdiction over decisions taken by the Director General of the Regional Health Agency pursuant to Articles L. 6145-1, L. 6145-2, L. 6145-3, L. 6145-4 and L. 6145-5.

The Director General of the Regional Health Agency shall refer to the Administrative Court the deliberations and decisions relating to these matters, with the exception of those covered by 5° of Article L. 6143-7, which he considers to be illegal within two months of receipt. It shall inform the institution without delay and provide it with details of the grounds for illegality cited. He may include in his appeal an application for a stay of execution.

Mariela Petrova

Need help applying this article to your situation?

A registered French Lawyer explains what applies to your business — in English, fixed fee.

within 48h

Fixed Fee

Talk to a lawyer
Common Questions

Working with a corporate lawyer in France — Q&A

Any time a strategic decision changes how the company is owned, governed or contractually bound — incorporation, fundraising, M&A, restructuring, shareholder agreements, or major commercial contracts. Earlier engagement always costs less than later remediation.

A notary (notaire) is a public officer who authenticates specific deeds (mainly real-estate transfers and certain family-law acts). A corporate lawyer (avocat) advises on strategy, negotiates and drafts company documents, and represents you in disputes. The two roles complement rather than overlap.

Yes — most of our clients are foreign suppliers, investors or holding entities. We bridge the gap between French law and your home jurisdiction's expectations and deliver everything bilingually.

The SAS (Société par Actions Simplifiée) is the default choice for most international structures: flexible governance, single shareholder allowed, no minimum capital, and works cleanly with foreign holding entities. We assess SARL, SA, SCI on the merits when the situation calls for it.

Yes — communications with a French avocat are protected by the secret professionnel (Article 66-5 of the Law of 31 December 1971). This protection is broader than the common-law attorney-client privilege and applies to written and oral exchanges.

We work on fixed fees for clearly scoped engagements (incorporation, contract drafting, audits) and on monthly retainers for ongoing advisory. Hourly billing is the exception, not the default. You always know the cost before work starts.

Typical timeline is 2–3 weeks from KYC kick-off to RCS registration, assuming standard documentation. Holding-company structures, foreign-shareholder identification or in-kind contributions can extend this — we flag the gating items at the first meeting.

Absolutely. We routinely coordinate with your in-house counsel, expert-comptable or notaire — pragmatic collaboration is the norm, not the exception. We send them everything they need to do their part without duplicating work.

Mariela Petrova

Mariela Petrova

Avocate au Barreau de Paris

Toque #C2396

15+ Years In Corporate Practice

English · French · Russian

Ready When You Are

Talk To A Corporate
Lawyer In France.

A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.

First EngagementFixed Fee

Talk to a French lawyer.

Reply within 24 hours.

Communications protected by professional secrecy — secret professionnel de l'avocat, Article 66-5 of the Law of 31 December 1971.

Continue Reading

Related corporate services in France

01 / Setup

Setting up a French company

Choose between SAS, SARL, SA or SCI — and structure your first French entity around how you actually plan to operate.

Read More
02 / Operating

French commercial contracts

Distribution, agency, supply, services and IP licences — drafted around the protections French law actually gives.

Read More
03 / Disputes

Business disputes & litigation

Shareholder conflicts, commercial breaches and pre-litigation strategy — handled by the same team that knows the file.

Read More